Skip to NavigationSkip to content

NICE recommends Pfizer's Vizimpro, rejects AstraZeneca's Tagrisso, in non-small cell lung cancer

Published on 05/07/19 at 09:39am

NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a U-turn on its previous decision to reject the drug for being an ineffective use of NHS resources.

The recommendation, made after the manufacturer agreed to a confidential discount, will make the drug available on the health service specifically in locally advanced or metastatic NSCLC, that has tested positive for the epidermal growth factor receptor (EGFR) mutation. It is thought that around 1,477 patients will be eligible to receive the drug per year.

The ruling was backed up by data which showed that patients using the therapy achieved longer overall survival times, measured as 34.1 months compared to 26.8 months for those using AstraZeneca’s NICE-approved Iressa (gefitinib). Additionally, Vizimpro led to longer progression-free survival times of 14.7 months compared to 9.2 months with Iressa, although it was noted that the drug showed a higher incidence of side-effects.

“Our committee acknowledged that dacomitinib had the potential to extend life for people with this type of lung cancer more than existing treatments currently available on the NHS,” commented Meindert Boysen, Director of the Centre for Health Technology Evaluation at NICE. “Responsible pricing by the company has allowed our committee to reconsider their initial decision. This has led to the positive recommendation announced today, allowing patients to benefit from this innovative treatment on the NHS.”

The news of the ruling was accompanied by the announcement that NICE had decided not to give a positive decision to AstraZeneca’s Tagrisso (osimertinib) in the same indication, deeming it an inefficient use of NHS resources.

AstraZeneca made it known that it plans to appeal the decision. CEO Pascal Soriot remarked on the decision: “We are very disappointed with this decision and will appeal. The UK has the second worst lung cancer survival outcomes in Europe and patients need new innovative treatments. NHS data show that the patients in England who would be eligible for first-line treatment with our medicine have very low survival rates and therefore Tagrisso should qualify for End of Life consideration to evaluate cost-effectiveness. Despite this, NICE has decided these data and the unprecedented benefits of our medicine are not enough to grant EoL criteria. As a consequence lung cancer patients in England will be deprived of a much needed new treatment option that is already available to patients in many other European countries and around the world.

“It is time for a comprehensive review of how NICE values innovative medicines," he continued. "This is needed to ensure British patients can access the latest medical advances, to support the ambitions of the NHS Long Term Plan to improve outcomes for people with cancer, and to help deliver Government’s ambition that the UK continues to be a globally leading centre for life sciences. Sadly in this instance, Tagrisso, a British discovery, will not be available to patients in England when many countries around the world have already decided to reimburse this medicine.”

Matt Fellows

Comments

It is a great website.. The Design looks very good.. Keep working like that!. order kratom

Thanks for sharing the post.. parents are worlds best person in each lives of individual..they need or must succeed to sustain needs of the family. Hanging Swing

I found your this post while searching for some related information on blog search...Its a good post..keep posting and update the information Psychologist Newport Beach

What a fantabulous post this has been. Never seen this kind of useful post. I am grateful to you and expect more number of posts like these. Thank you very much. commercial roofing

Hi! Thanks for the great information you havr provided! You have touched on crucuial points! Cayucos painting company

Love what you're doing here guys, keep it up!.. iPhone repair fort wayne

Your website is really cool and this is a great inspiring article. dog cupcakes

I recently found many useful information in your website especially this blog page. Among the lots of comments on your articles. Thanks for sharing. Chicago wedding Photography

Great! It sounds good. Thanks for sharing.. masonry contractor

Excellent information on your blog, thank you for taking the time to share with us. Amazing insight you have on this, it's nice to find a website that details so much information about different artists. gm1

This is my first time visit here. From the tons of comments on your articles,I guess I am not only one having all the enjoyment right here! 스포츠토토

This article gives the light in which we can observe the reality. This is very nice one and gives indepth information. Thanks for this nice article. Mobilité internationale

This is a great post. I like this topic.This site has lots of advantage.I found many interesting things from this site. It helps me in many ways.Thanks for posting this again. Dog

This is truly a great read for me. I have bookmarked it and I am looking forward to reading new articles. Keep up the good work!. Acupuncture

Nice blog and absolutely outstanding. You can do something much better but i still say this perfect.Keep trying for the best. maryland self-defense training

I am very much pleased with the contents you have mentioned. I wanted to thank you for this great article. Plateforme de relocation

Thank you for helping people get the information they need. Great stuff as usual. Keep up the great work!!! outcall massage

Wonderful blog! I found it while surfing around on Yahoo News. Do you have any suggestions on how to get listed in Yahoo News? I’ve been trying for a while but I never seem to get there! Appreciate it. locksmith

Keep up the good work , I read few posts on this web site and I conceive that your blog is very interesting and has sets of fantastic information. swimwear for girls

I am unable to read articles online very often, but I’m glad I did today. This is very well written and your points are well-expressed. Please, don’t ever stop writing. sell my test strips online

This blog website is pretty cool! How was it made ! tattoo parlors in fayetteville nc

I am unable to read articles online very often, but I’m glad I did today. This is very well written and your points are well-expressed. Please, don’t ever stop writing. career consultant

Keep up the good work , I read few posts on this web site and I conceive that your blog is very interesting and has sets of fantastic information. places to print documents near me

Thank you a bunch for sharing this with all of us you actually realize what you are talking about! Bookmarked. Please also seek advice from my site =). We could have a hyperlink change contract between us! brisbane wedding photographer

i am always looking for some free stuffs over the internet. there are also some companies which gives free samples. nj real estate

Hello There. I found your blog using msn. This is an extremely well written article. I will be sure to bookmark it and return to read more of your useful information. Thanks for the post. I’ll certainly comeback. decide teaching materials

Thanks for your post. I’ve been thinking about writing a very comparable post over the last couple of weeks, I’ll probably keep it short and sweet and link to this instead if thats cool. Thanks. Honolulu photographers

I recently came across your blog and have been reading along. I thought I would leave my first comment. I don’t know what to say except that I have enjoyed reading. Nice blog, I will keep visiting this blog very often. More hints

I am very happy to discover your post as it will become on top in my collection of favorite blogs to visit. عربي

Thanks for sharing nice information with us. i like your post and all you share with us is uptodate and quite informative, i would like to bookmark the page so i can come here again to read you, as you have done a wonderful job. http://www.hf-dog.com/low-cost-bravecto-online

Thank you for some other informative blog. Where else could I get that type of information written in such an ideal means? I have a mission that I’m just now working on, and I have been at the look out for such information. Animes to watch during during summer

Thanks for your post. I’ve been thinking about writing a very comparable post over the last couple of weeks, I’ll probably keep it short and sweet and link to this instead if thats cool. Thanks. Click here

Great! It sounds good. Thanks for sharing.. free tour stockholm

thanks for the tips and information..i really appreciate it.. free tour stockholm

This is a great inspiring article.I am pretty much pleased with your good work.You put really very helpful information. Keep it up. Keep blogging. Looking to reading your next post. an article to keto pure

Hi there! Nice post! Please tell us when I will see a follow up! moving boxes

Your website is really cool and this is a great inspiring article. More Bonuses

If more people that write articles really concerned themselves with writing great content like you, more readers would be interested in their writings. Thank you for caring about your content. their website

This is very educational content and written well for a change. It's nice to see that some people still understand how to write a quality post.! my site

Thank you very much for this great post. check this

Thanks for providing recent updates regarding the concern, I look forward to read more. other

i really like this article please keep it up. useful site

i really like this article please keep it up. browse around these guys

I am very much pleased with the contents you have mentioned. I wanted to thank you for this great article. web

Superbly written article, if only all bloggers offered the same content as you, the internet would be a far better place.. security company in Nottingham

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches